Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma
JAMA Author Interviews - Ein Podcast von JAMA Network
Interview with Antoni Ribas, MD, PhD, author of Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
